Trials / Recruiting
RecruitingNCT06554509
Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 236 (estimated)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with Prurigo Nodularis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-1819 injection | SHR-1819 injection |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2024-09-19
- Primary completion
- 2026-06-25
- Completion
- 2026-08-20
- First posted
- 2024-08-15
- Last updated
- 2024-10-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06554509. Inclusion in this directory is not an endorsement.